Episode 64 of the Seeing Beyond Risk podcast discusses the evolving landscape of mental health along with the impact of mental health claims on group benefits plans and proposes many interesting strategies to help organizations mitigate rising costs. But things are not so simple when it comes to mental health and there are many aspects to consider. Here we will delve deeper into some of the...
CIA public statement on pharmacare
The CIA has released a public statement entitled “Pharmacare: Is There a Pill for That?” outlining the profession’s thoughts on how a nationwide framework to provide prescription drug coverage for Canadians should be structured. In this episode, we hear from Paul Kennedy, FCIA, a member of the task force that authored the statement, as he outlines some of the statement’s key messages.
Placing an actuarial seat at the pharmacare table
The principle that all Canadians should have access to affordable health care is a deeply rooted Canadian value. This is why, for more than 50 years, studies commissioned by the federal government have come back saying the same thing – prescription drugs should be part of medicare. And, if you asked most Canadians today, they would support the principle that all of us should have access to the...
In memoriam: Claude Castonguay (1929–2020)
Morbidity considerations in the time of COVID-19
The impact of COVID-19 on morbidity experience is still unknown at this stage. In this article, Mario St-Hilaire and Steve Turmel discuss the key considerations that relate to the assumption-setting process for morbidity in these unprecedented times.